Acuerdo Marco para el suministro de medicamentos exclusivos para el Hospital Universitario Marqués de Valdecilla.
Awarded
The competition has ended and a winner has been selected.
- Award
- Rappel por consumo 20%
- Procedure
- Without prior noticeTwo stages
Brief
El Servicio Cántabro de Salud ha adjudicado un acuerdo marco a JANSSEN CILAG, S.A., VERTEX PHARMACEUTICALS SPAIN, S.L., GILEAD SCIENCES, S.L., NOVARTIS FARMACEUTICA, S.A. y BRISTOL MYERS SQUIBB, S.A.U. para el suministro de medicamentos exclusivos al Hospital Universitario Marqués de Valdecilla en Cantabria. El contrato tiene una duración de 24 meses y un valor máximo total de 82.436.694,35 EUR. Los criterios de adjudicación fueron la oferta económica (80%) y el rappel por consumo (20%). Solo se recibió una oferta.
Farmasøytisk engroshandel
Result
- BRISTOL MYERS SQUIBB, S.A.UWinner
- GILEAD SCIENCES, S.L.Winner
- JANSSEN CILAG, S.A.Winner
- NOVARTIS FARMACEUTICA, S.A.Winner
- VERTEX PHARMACEUTICALS SPAIN, S.L.Winner
- 1Number of tenders received
- Not statedContract value
- Maximum framework agreement valueUp to €82,436,694
Custom Assessment Criteria
Get answers to your bid/no-bid criteria
Set them up once and Cobrief answers them in every tender
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
Oferta económica.
Source
No source found in the documents. Check the weight against the tender documents.
Description
Rappel por consumo.
Source
No source found in the documents. Check the weight against the tender documents.
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Servicio Cántabro de Salud
From the notice
Acuerdo Marco para el suministro de medicamentos exclusivos para el Hospital Universitario Marqués de Valdecilla.
Contact
Servicio Cántabro de Saludcontratacion.dg@scsalud.es- Result · Framework agreement · PrequalificationType
- CantabriaLocation
- 33600000Main codePharmaceutical products